For ePRO, Symfo touts wireless technology that uses audible signals sent over plain old telephone lines. more...

A major win for the Boston e-diary company, with two pivotal studies that enrolled 1,076 adolescents. more...

In real time, a small, innovative pharma uses e-diaries to secure insights into diabetic patients—and into operational metrics. more...

Given uncertainty about the re-marriage of hardware and software from industry titan Palm, etrials thinks the industry will be obliged to take a hard look at Windows Mobile. Linux, anyone? more...

A key developer of tools for interactive voice response systems has resolved its differences with clinical technology suite ClinPhone. The pact was announced last week, and got buried in our email. more...

In a news release, etrials said the study “will capture patient-reported outcomes as they relate to the safety and tolerability of a drug within a pediatric-patient population across 420 individual sites in Europe and North America.” more...

The diary company CRF tells ClinPage about its respiratory subspecialty and other recent news. more...

PHT chief says the current growth may not dampen for years: “They’re not coming forward with one or two studies. They show up with five studies over a 2-year period.” more...

The company said that making sure the device works on the patchwork network of U.S. mobile telephone carriers is one issue. more...

Almac’s Fritz Haas says: “When these technologies work together, there will be synergies in terms of data quality and getting the data accessible in reports and submissions.” more...

The case could ultimately raise the costs associated with clinical trials that use handheld devices. Palm, in a statement, said: “Palm is disappointed that, after many months of silence and repeated rejections of NTP’s claims by the PTO, NTP has chosen to sue on patents of doubtful validity.” more...

In an online presentation, the consulting arm of invivodata, the Pittsburgh ediary firm, channels FDA thinking on making sure electronic diaries are as rigorously designed as paper equivalents. more...

In addition to going public in London this year, the company has recently opened new offices in California and North Carolina, expanded its Chicago operation, and relocated its main U.S. office, in New Jersey, to larger premises. more...

One September contract, etrials said, involves the expansion of a large trial for a top 10 global pharmaceutical company involving 25 clinical sites and 100,000 patients. more...

The diary firm says 10,000 people are now certified to use its platform. The company’s network of contract research organizations is also growing, and now includes 8 of the top 10 CROs. more...

Diary company to discuss anxiety trials. more...